Abstract
To the Editor: COVID-19 clinical trials and media attention have led to public familiarity with hydroxychloroquine (HCQ). Attention has been drawn to rare HCQ adverse effects, such as severe arrhythmia and cardiomyopathy.1 Anecdotally, patients have contacted us regarding such adverse effects, despite being on long-term HCQ without issue. The purposes of this study were to characterize dermatologists' HCQ practice habits and to determine if the COVID-19 pandemic has affected these habits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
